Series A Therapeutics Companies

ai3Bio develops treatments to transform the lives of patients with cancer.

Biolevate provides an AI platform for life sciences teams to manage regulated operations through evidence-driven, auditable workflows.

Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.

Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions.

ReEmerge is a medical technology company that specializes in cognitive network restoration therapy.

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

KaliVir Immunotherapeutics develops oncolytic viral immunotherapy programs for the treatment of cancer.

Leal Therapeutics develops novel therapeutics for patients.

Telum Therapeutics is a biotechnology company that develops antimicrobial therapies to combat multidrug-resistant bacterial infections.

Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.

Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Oorja Bio is is a clinical-stage biotechnology company focused on developing therapies.

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

Axoft is a revolutionary seamless interface between brain and machine.

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

Bone Health Technologies is developing a new standard of care for treating osteopenia, the precursor to osteoporosis.

R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.

NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.